Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
JAK blockade and HTLV
Lee Ratner
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Section of Molecular Oncology & Developmental Therapeutics
Division of Oncology
DBBS - Molecular Microbiology and Microbial Pathogenesis
DBBS - Molecular Genetics and Genomics
DBBS - Cancer Biology
Research output
:
Contribution to journal
›
Comment/debate
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'JAK blockade and HTLV'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Human T-cell Leukemia Virus Type 1 (HTLV-1)
100%
IL-9
50%
Interleukin-2
50%
Paracrine
50%
Selective Inhibitor
50%
Interleukin-15 (IL-15)
50%
Lymphocyte Proliferation
50%
JAK3
50%
Medicine and Dentistry
Human T Cell Leukemia Virus
100%
Interleukin 2
50%
Lymphocyte Proliferation
50%
Interleukin 15
50%
Janus Kinase 3
50%
Pharmacology, Toxicology and Pharmaceutical Science
Human T Cell Leukemia Virus
100%
Interleukin 2
50%
Interleukin 15
50%
Janus Kinase 3
50%